SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 68 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |